Cochlear Nucleus CR120 intraoperative remote assistant. Manufactured and submitted by Cochlear Ltd. (Macquarie University, Australia). The Cochlear Nucleus CR120 intraoperative remote assistant is a ...
CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 ...
LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
Hosted on MSN
Cochlear Limited’s Remote Care Study: A Potential Game-Changer in Hearing Implant Management
Cochlear Limited ((CHEOF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming ...
Amid COVID-19 uncertainty and patent battle loss, Cochlear raises AU$880M, rolls out remote solution
PERTH, Australia – Cochlear Ltd., of Sydney, is gearing up to launch its new Remote Check solution for cochlear implant users on the heels of an AU$880 million (US$559 million) capital raise and a ...
Cochlear Limited, the world leader in implantable hearing solutions, has received US Food and Drug Administration approval for the first remote feature to allow follow-up programming sessions for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results